ScholarIQanswers from OpenAlex

Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort

PaperCitations, authors & open-access status

Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort have?

ScholarIQcitation count

Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort has 93 citations in the OpenAlex counts ScholarIQ stores.

When was Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort published?

ScholarIQyear

Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort has 2015 year in the ScholarIQ index.

What is the open-access status of Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort?

ScholarIQoa status

Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort has bronze oa status in the ScholarIQ index.

What is the DOI of Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort?

ScholarIQdoi

The DOI for Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort is on the source record.

What is the PMID of Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort?

ScholarIQpmid

The PMID for Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort is on the source record.

What is the OpenAlex record for Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort?

ScholarIQopenalex

The OpenAlex for Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial